AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update
Top Cited Papers
- 16 July 2002
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (3) , 388-391
- https://doi.org/10.1161/01.cir.0000020190.45892.75
Abstract
He initial Guide to the Primary Prevention of Cardiovas- cular Diseases was published in 1997 as an aid to healthcare professionals and their patients without established coronary artery disease or other atherosclerotic diseases. 1 It was intended to complement the American Heart Association (AHA)/American College of Cardiology (ACC) Guidelines for Preventing Heart Attack and Death in Patients with Atherosclerotic Cardiovascular Disease (updated2) and to provide the healthcare professional with a comprehensive approach to patients across a wide spectrum of risk. The imperative to prevent the first episode of coronary disease or stroke or the development of aortic aneurysm and peripheral arterial disease remains as strong as ever because of the still-high rate of first events that are fatal or disabling or require expensive intensive medical care. The evidence that most cardiovascular disease is preventable continues to grow. Results of long-term prospective studies consistently identify persons with low levels of risk factors as having lifelong low levels of heart disease and stroke. 3,4 Moreover, these low levels of risk factors are related to healthy lifestyles. Data from the Nurses Health Study,5 for example, suggest that in women, maintaining a desirable body weight, eating a healthy diet, exercising regularly, not smoking, and consuming a moderate amount of alcohol could account for an 84% reduction in risk, yet only 3% of the women studied were in that category. Clearly, the majority of the causes of cardio- vascular disease are known and modifiable.Keywords
This publication has 11 references indexed in Scilit:
- Aspirin for the Primary Prevention of Cardiovascular Events: Recommendation and RationaleAnnals of Internal Medicine, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and ElectrophysiologyEuropean Heart Journal, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Optimal risk factors in the population: prognosis, prevalence, and secular trends. Data from Göteborg population studiesPublished by Oxford University Press (OUP) ,2001
- Primary Prevention of Coronary Heart Disease in Women through Diet and LifestyleNew England Journal of Medicine, 2000
- Vitamin E Supplementation and Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Low Risk-Factor Profile and Long-term Cardiovascular and Noncardiovascular Mortality and Life ExpectancyJAMA, 1999
- Executive SummaryObesity Research, 1998
- Task force 8. Organization of preventive cardiology serviceJournal of the American College of Cardiology, 1996